primary immune thrombocytopenia (itp)
Showing 1 - 7 of 7
Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)
Not yet recruiting
- Primary Immune Thrombocytopenia (ITP)
- Ianalumab
- (no location specified)
Jun 5, 2023
Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)
Not yet recruiting
- Primary Immune Thrombocytopenia (ITP)
- TPO-RAs
- TPO-RAs combining anti-CD 20 monoclonal antibody
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Aca
Feb 7, 2023
Primary Immune Thrombocytopenia (ITP) Trial in Singapore (Ianalumab, Placebo, Corticosteroids)
Recruiting
- Primary Immune Thrombocytopenia (ITP)
- Ianalumab
- +2 more
-
Singapore, SingaporeNovartis Investigative Site
Jan 17, 2023
Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):
Recruiting
- Primary Immune Thrombocytopenia (ITP)
- Eltrombopag (Revolade®)
- standard therapy (without eltrombopag): HD-DXM
-
Aarau, Switzerland
- +5 more
Sep 5, 2022
Primary Immune Thrombocytopenia (ITP) Trial (Combination of Rituximab with subcutaneous belimumab, Combination of Rituximab with
Not yet recruiting
- Primary Immune Thrombocytopenia (ITP)
- Combination of Rituximab with subcutaneous belimumab
- Combination of Rituximab with subcutaneous placebo
- (no location specified)
Apr 15, 2022
Primary Immune Thrombocytopenia (ITP) Trial (efgartigimod, Placebo)
Withdrawn
- Primary Immune Thrombocytopenia (ITP)
- efgartigimod
- Placebo
- (no location specified)
Sep 11, 2020
Study of Immune Thrombocytopenia Pathogenesis:
Completed
- Primary Immune Thrombocytopenia (ITP)
- Blood samples
- Spleen samples
-
Besançon, France
- +2 more
Mar 13, 2018